<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Entero Healthcare Solutions has filed its initial disclosure for FY2024-25 confirming it does NOT qualify as a 'Large Corporate' under SEBI's framework for debt securities issuance. The company's outstanding borrowing as of 31st March 2025 is NIL, meaning it is not required to make additional borrowing disclosures or face penalties for shortfalls. Its credit rating stands at IND A-/Stable from India Ratings and Research (a Fitch Group company). The filing was submitted by Sanu Kapoor (Company Secretary) and Balakrishnan Natesan Kaushik (CFO) on April 28, 2025.
This is a routine regulatory compliance filing with no direct material impact on shareholders. However, it reveals that the company currently has zero outstanding borrowings and carries a moderate investment-grade credit rating, suggesting a debt-free balance sheet.